Å·ÃÀAV

Introduction

Pharmacogenomics is being implemented now and is already have an impact in the clinical setting and in healthcare. Employing a pharmacogenomics strategy with marketed drugs can mitigate risk by avoiding adverse events, allowing the identification of patients most likely to benefit from a drug, and thereby improving patient compliance and safety. Tangible benefits of pharmacogenomics and resequencing technologies will be presented, and the value of this approach will be demonstrated.

Venue

Hotel Omni Mont-Royal

Hotel Omni Mont-Royal, Montreal, Quebec, Canada

Useful links

Organised by

Cambridge Healthtech Institute

Contact information

CHI Representative
United States of America
+ 781 972 5400
Contact us by email

---